
263: Biogen's messy board, Laronde's data problem, & the downside of a boom
The Readout Loud
00:00
Theranos and the Biotech Industry
One of the interesting things was how many biotech people really felt comfortable sharing your story publicly. You know, this is an industry that tends to close ranks in public. I would suspect that people in the biotech industry are well aware of the fact that we as an industry need to ... not kind of bury it under the rug,. We need to address it and, you know, hopefully show people, as Jane said at the end of my piece, that this is, this is not what biotech is.
Transcript
Play full episode